KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Times Interest Earned (2016 - 2025)

Ionis Pharmaceuticals has reported Times Interest Earned over the past 17 years, most recently at -$44.42 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$44.42 for Q4 2025, down 67.99% from a year ago — trailing twelve months through Dec 2025 was -$22.11 (up 20.91% YoY), and the annual figure for FY2025 was -$22.11, up 20.91%.
  • Times Interest Earned for Q4 2025 was -$44.42 at Ionis Pharmaceuticals, down from -$38.03 in the prior quarter.
  • Over the last five years, Times Interest Earned for IONS hit a ceiling of $98.57 in Q4 2021 and a floor of -$120.17 in Q4 2022.
  • Median Times Interest Earned over the past 5 years was -$35.74 (2024), compared with a mean of -$28.26.
  • Biggest five-year swings in Times Interest Earned: surged 1158.61% in 2021 and later crashed 1868.73% in 2024.
  • Ionis Pharmaceuticals' Times Interest Earned stood at $98.57 in 2021, then tumbled by 221.91% to -$120.17 in 2022, then surged by 98.88% to -$1.34 in 2023, then crashed by 1868.73% to -$26.44 in 2024, then crashed by 67.99% to -$44.42 in 2025.
  • The last three reported values for Times Interest Earned were -$44.42 (Q4 2025), -$38.03 (Q3 2025), and $33.99 (Q2 2025) per Business Quant data.